A Multicenter Patient Registry for Outcomes of Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome Treatment

What this Trial Is About

Researchers are collecting real-world data on the safety and performance of AtriCure devices used to treat heart rhythm conditions called Inappropriate Sinus Tachycardia (IST) and Postural Tachycardia Syndrome (POTS). This study is observational, meaning it looks at data from patients who have already had or will have these treatments, without assigning specific treatments to participants. The registry includes multiple centers in the US and other countries to gather diverse information. The study focuses on patients who have undergone or are scheduled for a cardiac ablation procedure using AtriCure devices. These devices are used in epicardial and endocardial hybrid ablation to target heart tissue responsible for IST or POTS symptoms. The registry collects data retrospectively and prospectively, monitoring outcomes up to 12 months after treatment. Participants contribute by allowing researchers to collect and analyze their treatment and health data related to the use of AtriCure devices. The main outcome measured is the use and performance of these devices over a year. Since this is an observational registry, no additional treatments or procedures are required beyond routine care, and participant safety is monitored through the collected data. The study is expected to continue until January 2027.

Inappropriate Sinus Tachycardia Registry